CHEMOS
ALC-0315

ALC-0315

Chemical Name

6-[6-(2-hexyldecanoyloxy)hexyl-(4-hydroxybutyl)amino]hexyl 2-hexyldecanoate

ALC-0315•LNP
Structure: ALC-0315 structure, CAS 2036272-55-4, MW 766.27
Product No
CH51010
CAS
2036272-55-4
MF
C48H95NO5
MW
766.27
Specification
Catalog No.CH51010
CAS No.2036272-55-4
Molecular FormulaC48H95NO5
Molecular Weight766.27

CHEMOS Support for This Category

CHEMOS supports custom synthesis and process development for LNP lipid components, with work planned according to target structure, requested scale, and analytical requirements. Ionizable lipid route development : route scouting, impurity review, stereochemistry control, and purification planning. Helper lipid and PEG-lipid preparation : support for phospholipids, sterol-related components, PEG-lipids, and related analogs. Analytical support : HPLC, NMR, MS, Karl Fischer water content, elemental analysis, and residual-solvent testing can be discussed by project. Scale-up support : transfer from laboratory preparation to larger pilot or production batches after route and quality review. Project documentation : batch-specific COA and technical information are provided according to the confirmed specification.

Overview

ALC-0315 (also known as 6-[6-(2-hexyldecanoyloxy)hexyl-(4-hydroxybutyl)amino]hexyl 2-hexyldecanoate) (CAS 2036272-55-4, MF C48H95NO5, MW 766.27) is an ionizable cationic lipid analog used in LNP formulation research. Common chemistry questions involve scalable preparation of the lipid backbone, analog screening, and impurity control across batches. Bench-scale to larger-scale production is supported through CHEMOS organic chemistry workflows and dedicated process-development resources.

Applications

  • ALC-0315 (CAS 2036272-55-4) route review and custom analog preparation
  • Custom analog synthesis with controlled head-group and tail variants
  • Reference comparator in next-generation ionizable lipid programs
  • Analytical method development for ionizable lipid related substances

Need Custom Synthesis?

Our CDMO team provides end-to-end custom synthesis support from discovery through process development and scale-up.

Explore CDMO Services